GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » FCF Yield %

BioNote (XKRX:377740) FCF Yield % : 4.25 (As of Jun. 08, 2024)


View and export this data going back to 2022. Start your Free Trial

What is BioNote FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BioNote's Trailing 12-Month Free Cash Flow is ₩18,104 Mil, and Market Cap is ₩425,574 Mil. Therefore, BioNote's FCF Yield % for today is 4.25%.

The historical rank and industry rank for BioNote's FCF Yield % or its related term are showing as below:

XKRX:377740' s FCF Yield % Range Over the Past 10 Years
Min: -3.42   Med: 2.37   Max: 41.97
Current: 4.25


During the past 5 years, the highest FCF Yield % of BioNote was 41.97%. The lowest was -3.42%. And the median was 2.37%.

XKRX:377740's FCF Yield % is ranked better than
85.33% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: -2.73 vs XKRX:377740: 4.25

BioNote's FCF Margin % for the quarter that ended in Mar. 2024 was 42.32%.


BioNote FCF Yield % Historical Data

The historical data trend for BioNote's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNote FCF Yield % Chart

BioNote Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - - 23.64 -2.02

BioNote Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.80 -12.69 16.09 2.19 9.76

Competitive Comparison of BioNote's FCF Yield %

For the Medical Devices subindustry, BioNote's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNote's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioNote's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BioNote's FCF Yield % falls into.



BioNote FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BioNote's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-8735.625 / 433227.72
=-2.02%

BioNote's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=10711.791 * 4 / 438840.8
=9.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNote FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BioNote FCF Yield % Related Terms

Thank you for viewing the detailed overview of BioNote's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNote (XKRX:377740) Business Description

Traded in Other Exchanges
N/A
Address
22, Samsung 1-ro 4-gil, Gyeonggi-do, Hwaseong-si, KOR
BioNote Inc is a manufacturer of diagnostic kits and equipment for animal diseases and is equipped with a wide product portfolio, from initial screening tests to molecular diagnosis. Its animal diagnostics products comprise of Vcheck F, Vcheck M, Vcheck C, Rapid, and ELISA.

BioNote (XKRX:377740) Headlines

No Headlines